Jazz Pharmaceuticals: Q3 Earnings Insights

Jazz Pharmaceuticals JAZZ reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Jazz Pharmaceuticals missed estimated earnings by 1.43%, reporting an EPS of $4.84 versus an estimate of $4.91.

Revenue was up $31.49 million from the same period last year.

Last quarter the company beat on EPS by $0.08 which was followed by a 1.64% increase in the share price the next day.

Here's a look at Jazz Pharmaceuticals's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	4.43	4.24	0.32	4.66
EPS Actual	4.51	3.95	-0.07	5.17
Revenue Estimate	942.86M	895.37M	975.59M	939.06M
Revenue Actual	957.32M	892.81M	972.12M	940.65M

To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar